Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

SWTX holding history

SpringWorks Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SWTX overviewAll 13F holders of SWTXFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of SWTX by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−1,247,783−100.0%Sold outHolders
Q2 20251,247,783$58.6M<0.1%+352,208+39.3%AddedHolders
Q1 2025895,575$39.5M<0.1%−1,101,701−55.2%ReducedHolders
Q4 20241,997,276$72.2M<0.1%+558,641+38.8%AddedHolders
Q3 20241,438,635$46.1M<0.1%+1,112,516+341.1%AddedHolders
Q2 2024326,119$12.3M<0.1%−254,943−43.9%ReducedHolders
Q1 2024581,062$28.6M<0.1%+10,398+1.8%AddedHolders
Q4 2023570,664$20.8M<0.1%+42,702+8.1%AddedHolders
Q3 2023527,962$12.2M<0.1%+187,088+54.9%AddedHolders
Q2 2023340,874$8.94M<0.1%+12,969+4.0%AddedHolders
Q1 2023327,905$8.44M<0.1%−41,781−11.3%ReducedHolders
Q4 2022369,686$9.62M<0.1%−385,931−51.1%ReducedHolders
Q3 2022755,617$21.6M<0.1%+257,965+51.8%AddedHolders
Q2 2022497,652$12.3M<0.1%+347,754+232.0%AddedHolders
Q1 2022149,898$8.46M<0.1%+61,623+69.8%AddedHolders
Q4 202188,275$5.47M<0.1%−24,961−22.0%ReducedHolders
Q3 2021113,236$7.18M<0.1%+32,035+39.5%AddedHolders
Q2 202181,201$6.69M<0.1%−52,665−39.3%ReducedHolders
Q1 2021133,866$9.85M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.